High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction
- 12 December 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 114 (24), 2604-2610
- https://doi.org/10.1161/circulationaha.106.634626
Abstract
Background— Aldosterone, the final mediator of the renin-angiotensin-aldosterone pathway, is at its highest plasma levels at presentation for ST-elevation myocardial infarction (STEMI). Whether ald...Keywords
This publication has 25 references indexed in Scilit:
- Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ N G -Nitro- l -Arginine Methyl Ester-Induced Myocardial InjuryCirculation, 2003
- B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial InfarctionCirculation, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 βEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captoprilJournal of the American College of Cardiology, 1994
- Short- and long-term neurohormonal activation following acute myocardial infarctionAmerican Heart Journal, 1993
- Neuroendocrine activation after acute myocardial infarction.Heart, 1988
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Captopril in heart failure. A double blind controlled trial.Heart, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976